Director/PDMR Shareholding

RNS Number : 3051A

Hikma Pharmaceuticals Plc

23 March 2017

Notification and public disclosure of transactions by persons discharging managerial responsibilities

The attached individual notification made under article 19.1 of the Market Abuse Regulation ("MAR") relates to the disposal of Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC by the Chief Strategy and Corporate Development Officer. This announcement is made in accordance with article 19.3 of MAR.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Bassam Kanaan
2	Reason for the notification
a)	Position/status	Chief Strategy and Corporate Development Officer / PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Disposal of 43,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.
c)	Price(s) and volume(s)	Price(s): £21.22 Volume(s): 43,000
d)	Aggregated information	Aggregated volume: 43,000 Price: £21.22
e)	Date of the transaction	20 to 22 March 2017
f)	Place of the transaction	London Stock Exchange (XLON)